Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations.
The publication of the Australasian Creatinine Consensus Working Group's position statements in 2005 and 2007 resulted in automatic reporting of estimated glomerular filtration rate (eGFR) with requests for serum creatinine concentration in adults, facilitated the unification of units of measurement for creatinine and eGFR, and promoted the standardisation of assays. New advancements and continuing debate led the Australasian Creatinine Consensus Working Group to reconvene in 2010.  The working group recommends that the method of calculating eGFR should be changed to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula, and that all laboratories should report eGFR values as a precise figure to at least 90 mL/min/1.73 m(2). Age-related decision points for eGFR in adults are not recommended, as although an eGFR < 60 mL/min/1.73 m(2) is very common in older people, it is nevertheless predictive of significantly increased risks of adverse clinical outcomes, and should not be considered a normal part of ageing.If using eGFR for drug dosing, body size should be considered, in addition to referring to the approved product information. For drugs with a narrow therapeutic index, therapeutic drug monitoring or a valid marker of drug effect should be used to individualise dosing. The CKD-EPI formula has been validated as a tool to estimate GFR in some populations of non-European ancestry living in Western countries. Pending publication of validation studies, the working group also recommends that Australasian laboratories continue to automatically report eGFR in Aboriginal and Torres Strait Islander peoples. The working group concluded that routine calculation of eGFR is not recommended in children and youth, or in pregnant women. Serum creatinine concentration (preferably using an enzymatic assay for paediatric patients) should remain as the standard test for kidney function in these populations.
Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
David W
DW
Johnson
Graham R D
GR
Jones
Timothy H
TH
Mathew
Marie J
MJ
Ludlow
Matthew P
MP
Doogue
Matthew D
MD
Jose
Robyn G
RG
Langham
Paul D
PD
Lawton
Steven J
SJ
McTaggart
Michael J
MJ
Peake
Kevan
K
Polkinghorne
Tim
T
Usherwood
D000293:Adolescent; D000328:Adult; D044362:Australasia; D015415:Biomarkers / Q000097:blood; D002648:Child; D003404:Creatinine / Q000097:blood; D003661:Decision Support Techniques; D054796:Drug Dosage Calculations; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000175:diagnosis / Q000503:physiopathology; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000175:diagnosis* / Q000208:ethnology / Q000503:physiopathology; D018570:Risk Assessment
D015415:Biomarkers; D003404:Creatinine